J&J’s $3B acquisition could help beat drug resistance in prostate cancer

Johnson & Johnson is acquiring Halda Therapeutics for its lead program, a drug that recently posted encouraging Phase 1 data in advanced prostate cancer. This drug comes from a proprietary Halda platform technology that yields oral small molecules offering a novel mechanism for killing cancer cells.

Editor's Pick

Top Story J&J's $3B Halda Acquisition Brings a Way to Overcome Drug Resistance in Prostate Cancer & More Johnson & Johnson is acquiring Halda Therapeutics for its lead program, a drug that recently posted encouraging Phase 1 data in advanced prostate cancer. This drug comes from a proprietary Halda platform technology that yields oral small molecules offering a novel mechanism for killing cancer cells. Sponsored Shop and Compare: Online Health Insurance Options in California Presented by Health for California Here are some of the top online health insurance options worth exploring — each designed to simplify coverage decisions while meeting California's high standards for accessibility and compliance. Learn More

Featured News

How Sanford Health Embeds AI into Its EHR to Catch Disease Earlier & Personalize Care Sanford Health is embedding AI into its EHR to turn vast patient data into actionable insights. Tools like a chronic kidney disease module and a personalized colon cancer screening model are helping clinicians catch disease earlier and tailor care to individual patients, explained Jeremy Cauwels, the health system's chief medical officer.  Hospitals Can't Keep Staffing Like it's 1995 The time to prepare is now, while there's still time and space to figure out what works. Change is uncomfortable, but clinging to outdated habits is far riskier. StartUPDATES: New Developments for Healthcare Startups Check out news from Oral Genome, Beacon Biosignals, Modulight Therapeutics, No Barrier, and Lab Central. The Hidden Data Errors Delay Healthcare for Millions of Americans Network inaccuracy isn't an inconvenience – it's a public health crisis.

Video   Video: Looking for smarter health guidance? Carolyn Jasik from Verily talks about their telemedicine app linking users to licensed doctors and Violet, an AI that answers your health questions using your own medical records. Watch the interview to see how Verily is changing health access.

Resources

MedCity FemFwd: Inside Wellcome Leap and Pivotal's $100M Commitment To Women's Health In this episode, we're joined by Dr. Renee Wittemyer, vice president of program strategy at Pivotal Ventures, and Dr. Regina Dugan, CEO of Wellcome Leap. They discuss the organizations' recent $100 million commitment to accelerate women's health research. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe